Since the CD40/CD154 axis participates in the genesis of inflammatory conditions including atherosclerosis and neuroinflammation [32], [33], manipulation of this system by immunomodulatory agents such as atorvastatin would provide a useful means to shift the T cell response towards a regulatory phenotype. This evidence concerns the gene CD40 and atherosclerosis.